Sean Milmo

Sean Milmo is a freelance writer based in Essex, United Kingdom.

Despite its shrinking domestic economy, Ireland is determined not to let its pharmaceutical industry fade into the shadow of global recession.

Although industry is tightening its belt, contract manufacturers across Europe are actually making out quite well by taking on additional projects and new roles.

Although the European Union's approval rates of biosimilars for market is increasing slower than expected, its approach may provide an example for other foreign markets.

A growing preference for public-private partnerships is spurring innovation and technology among Dutch pharmaceutical companies.

With counterfeiting on the rise and Europeans worried their backyard is becoming a base for such illegal activity, legislators have proposed a series of solutions that span the continent and abroad.

A wave of pharmaceutical expansions is expected in Europe this year, surprisingly by Indian companies.